Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Income

v3.10.0.1
Condensed Consolidated Statements of Operations and Comprehensive Income - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Income Statement [Abstract]        
Revenues $ 0 $ 0 $ 0 $ 0
Operating expenses:        
Research and development 4,231 515 5,469 1,199
General and administrative 1,220 800 2,611 1,649
Depreciation 7 5 15 8
Total operating expenses 5,458 1,320 8,095 2,856
Loss from operations (5,458) (1,320) (8,095) (2,856)
Other income (expense):        
Gain (loss) from change in fair value of warrant liability 331 (3,342) 1,040 (2,283)
Gain from settlement of liability 0 0 0 149
Gain from expiration of warrants 0 1,238 0 1,238
Other income (expense) (1) 0 (1) (1)
Interest income (expense), net 3 0 4 (1)
Net loss $ (5,125) $ (3,424) $ (7,052) $ (3,754)
Net loss per common share – basic and diluted (in dollars per share) $ (0.20) $ (0.19) $ (0.29) $ (0.23)
Weighted-average common shares outstanding – basic and diluted 25,888,931 17,863,707 24,617,372 16,137,312
Net Loss $ (5,125) $ (3,424) $ (7,052) $ (3,754)
Foreign currency translation 6 0 6 0
Comprehensive loss $ (5,119) $ (3,424) $ (7,046) $ (3,754)